Fixation effect of surepath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry

Akihiko Kawahara, Tomoki Taira, Hideyuki Abe, Kosuke Watari, Yuichi Murakami, Chihiro Fukumitsu, Yorihiko Takase, Tomohiko Yamaguchi, Koichi Azuma, Jun Akiba, Mayumi Ono, Masayoshi Kage

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

BACKGROUND: Cytological diagnosis of respiratory disease has become important, not only for histological typing using immunocytochemistry (ICC) but also for molecular DNA analysis of cytological material. The aim of this study was to investigate the fixation effect of SurePath preservative fluids. METHODS: Human lung cancer PC9 and 11-18 cell lines, and lung adenocarcinoma cells in pleural effusion, were fixed in CytoRich Blue, CytoRich Red, 15% neutral-buffered formalin, and 95% ethanol, respectively. PC9 and 11-18 cell lines were examined by ICC with epidermal growth factor receptor (EGFR) mutation-specific antibodies, the EGFR mutation DNA assay, and fluorescence in situ hybridization. The effect of antigenic storage time was investigated in lung adenocarcinoma cells in pleural effusion by ICC using the lung cancer detection markers. RESULTS: PC9 and 11-18 cell lines in formalin-based fixatives showed strong staining of EGFR mutation-specific antibodies and lung cancer detection markers by ICC as compared with ethanol-based fixatives. DNA preservation with CytoRich Blue and CytoRich Red was superior to that achieved with 95% ethanol and 15% neutralbuffered formalin fixatives, whereas EGFR mutations by DNA assay and EGFR gene amplification by fluorescence in situ hybridization were successfully identified in all fixative samples. Although cytoplasmic antigens maintained high expression levels, expression levels in nuclear antigens fell as storage time increased. CONCLUSIONS: These results indicate that CytoRich Red is not only suitable for ICC with EGFR mutation-specific antibodies, but also for DNA analysis of cytological material, and is useful in molecular testing of lung cancer, for which various types of analyses will be needed in future.

Original languageEnglish
Pages (from-to)145-152
Number of pages8
JournalCancer Cytopathology
Volume122
Issue number2
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Fixatives
Epidermal Growth Factor Receptor
Immunohistochemistry
Lung Neoplasms
Mutation
Antibodies
DNA
Formaldehyde
Ethanol
Pleural Effusion
Fluorescence In Situ Hybridization
Cell Line
erbB-1 Genes
Neutral Red
Nuclear Antigens
Gene Amplification
Staining and Labeling
Antigens
Adenocarcinoma of lung

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Fixation effect of surepath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry. / Kawahara, Akihiko; Taira, Tomoki; Abe, Hideyuki; Watari, Kosuke; Murakami, Yuichi; Fukumitsu, Chihiro; Takase, Yorihiko; Yamaguchi, Tomohiko; Azuma, Koichi; Akiba, Jun; Ono, Mayumi; Kage, Masayoshi.

In: Cancer Cytopathology, Vol. 122, No. 2, 01.01.2014, p. 145-152.

Research output: Contribution to journalArticle

Kawahara, A, Taira, T, Abe, H, Watari, K, Murakami, Y, Fukumitsu, C, Takase, Y, Yamaguchi, T, Azuma, K, Akiba, J, Ono, M & Kage, M 2014, 'Fixation effect of surepath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry', Cancer Cytopathology, vol. 122, no. 2, pp. 145-152. https://doi.org/10.1002/cncy.21355
Kawahara, Akihiko ; Taira, Tomoki ; Abe, Hideyuki ; Watari, Kosuke ; Murakami, Yuichi ; Fukumitsu, Chihiro ; Takase, Yorihiko ; Yamaguchi, Tomohiko ; Azuma, Koichi ; Akiba, Jun ; Ono, Mayumi ; Kage, Masayoshi. / Fixation effect of surepath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry. In: Cancer Cytopathology. 2014 ; Vol. 122, No. 2. pp. 145-152.
@article{a1e11eebb1a94bbb954e631ff5cc1edf,
title = "Fixation effect of surepath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry",
abstract = "BACKGROUND: Cytological diagnosis of respiratory disease has become important, not only for histological typing using immunocytochemistry (ICC) but also for molecular DNA analysis of cytological material. The aim of this study was to investigate the fixation effect of SurePath preservative fluids. METHODS: Human lung cancer PC9 and 11-18 cell lines, and lung adenocarcinoma cells in pleural effusion, were fixed in CytoRich Blue, CytoRich Red, 15{\%} neutral-buffered formalin, and 95{\%} ethanol, respectively. PC9 and 11-18 cell lines were examined by ICC with epidermal growth factor receptor (EGFR) mutation-specific antibodies, the EGFR mutation DNA assay, and fluorescence in situ hybridization. The effect of antigenic storage time was investigated in lung adenocarcinoma cells in pleural effusion by ICC using the lung cancer detection markers. RESULTS: PC9 and 11-18 cell lines in formalin-based fixatives showed strong staining of EGFR mutation-specific antibodies and lung cancer detection markers by ICC as compared with ethanol-based fixatives. DNA preservation with CytoRich Blue and CytoRich Red was superior to that achieved with 95{\%} ethanol and 15{\%} neutralbuffered formalin fixatives, whereas EGFR mutations by DNA assay and EGFR gene amplification by fluorescence in situ hybridization were successfully identified in all fixative samples. Although cytoplasmic antigens maintained high expression levels, expression levels in nuclear antigens fell as storage time increased. CONCLUSIONS: These results indicate that CytoRich Red is not only suitable for ICC with EGFR mutation-specific antibodies, but also for DNA analysis of cytological material, and is useful in molecular testing of lung cancer, for which various types of analyses will be needed in future.",
author = "Akihiko Kawahara and Tomoki Taira and Hideyuki Abe and Kosuke Watari and Yuichi Murakami and Chihiro Fukumitsu and Yorihiko Takase and Tomohiko Yamaguchi and Koichi Azuma and Jun Akiba and Mayumi Ono and Masayoshi Kage",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/cncy.21355",
language = "English",
volume = "122",
pages = "145--152",
journal = "Cancer cytopathology",
issn = "1934-662X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Fixation effect of surepath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry

AU - Kawahara, Akihiko

AU - Taira, Tomoki

AU - Abe, Hideyuki

AU - Watari, Kosuke

AU - Murakami, Yuichi

AU - Fukumitsu, Chihiro

AU - Takase, Yorihiko

AU - Yamaguchi, Tomohiko

AU - Azuma, Koichi

AU - Akiba, Jun

AU - Ono, Mayumi

AU - Kage, Masayoshi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - BACKGROUND: Cytological diagnosis of respiratory disease has become important, not only for histological typing using immunocytochemistry (ICC) but also for molecular DNA analysis of cytological material. The aim of this study was to investigate the fixation effect of SurePath preservative fluids. METHODS: Human lung cancer PC9 and 11-18 cell lines, and lung adenocarcinoma cells in pleural effusion, were fixed in CytoRich Blue, CytoRich Red, 15% neutral-buffered formalin, and 95% ethanol, respectively. PC9 and 11-18 cell lines were examined by ICC with epidermal growth factor receptor (EGFR) mutation-specific antibodies, the EGFR mutation DNA assay, and fluorescence in situ hybridization. The effect of antigenic storage time was investigated in lung adenocarcinoma cells in pleural effusion by ICC using the lung cancer detection markers. RESULTS: PC9 and 11-18 cell lines in formalin-based fixatives showed strong staining of EGFR mutation-specific antibodies and lung cancer detection markers by ICC as compared with ethanol-based fixatives. DNA preservation with CytoRich Blue and CytoRich Red was superior to that achieved with 95% ethanol and 15% neutralbuffered formalin fixatives, whereas EGFR mutations by DNA assay and EGFR gene amplification by fluorescence in situ hybridization were successfully identified in all fixative samples. Although cytoplasmic antigens maintained high expression levels, expression levels in nuclear antigens fell as storage time increased. CONCLUSIONS: These results indicate that CytoRich Red is not only suitable for ICC with EGFR mutation-specific antibodies, but also for DNA analysis of cytological material, and is useful in molecular testing of lung cancer, for which various types of analyses will be needed in future.

AB - BACKGROUND: Cytological diagnosis of respiratory disease has become important, not only for histological typing using immunocytochemistry (ICC) but also for molecular DNA analysis of cytological material. The aim of this study was to investigate the fixation effect of SurePath preservative fluids. METHODS: Human lung cancer PC9 and 11-18 cell lines, and lung adenocarcinoma cells in pleural effusion, were fixed in CytoRich Blue, CytoRich Red, 15% neutral-buffered formalin, and 95% ethanol, respectively. PC9 and 11-18 cell lines were examined by ICC with epidermal growth factor receptor (EGFR) mutation-specific antibodies, the EGFR mutation DNA assay, and fluorescence in situ hybridization. The effect of antigenic storage time was investigated in lung adenocarcinoma cells in pleural effusion by ICC using the lung cancer detection markers. RESULTS: PC9 and 11-18 cell lines in formalin-based fixatives showed strong staining of EGFR mutation-specific antibodies and lung cancer detection markers by ICC as compared with ethanol-based fixatives. DNA preservation with CytoRich Blue and CytoRich Red was superior to that achieved with 95% ethanol and 15% neutralbuffered formalin fixatives, whereas EGFR mutations by DNA assay and EGFR gene amplification by fluorescence in situ hybridization were successfully identified in all fixative samples. Although cytoplasmic antigens maintained high expression levels, expression levels in nuclear antigens fell as storage time increased. CONCLUSIONS: These results indicate that CytoRich Red is not only suitable for ICC with EGFR mutation-specific antibodies, but also for DNA analysis of cytological material, and is useful in molecular testing of lung cancer, for which various types of analyses will be needed in future.

UR - http://www.scopus.com/inward/record.url?scp=84897957933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897957933&partnerID=8YFLogxK

U2 - 10.1002/cncy.21355

DO - 10.1002/cncy.21355

M3 - Article

VL - 122

SP - 145

EP - 152

JO - Cancer cytopathology

JF - Cancer cytopathology

SN - 1934-662X

IS - 2

ER -